glp-1 trials near me New Trial Shows Oral Aleniglipron May Be the Future GLP-1 Weight Loss Medications Explained:

Other than direct consequences, such as degenerative arthritis and sleep apnea, its controversial whether being overweight in and of itself causes a health risk

PATHOGENESIS OF MASLD/MASH The development and progression of MASLD/MASH involve intricate interconnections among multiple metabolic, inflammatory, and fibrogenic mechanisms [2,6,16]

[DOI] [PMC free article] [PubMed] [Google Scholar] 107.The Glucagon-like peptide-1 receptor agonist, exendin-4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome

This is similar to semaglutide's effect on food consumption in that we see people stop eating sooner, which is how people lose weight on semaglutide, he says